One patient with thyroid cancer and another with early-stage colorectal cancer resumed TNF inhibitor therapy after surgical resection due to persistent pain and uncontrolled disease activity; both remained recurrence-free during ≥5 years of follow-up. This evidence concerns the gene TNF and thyroid gland carcinoma.